Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | ICMT | O60725 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28186420 | 0.86 | ESR1 (0.32) | ALDH1A1 | |
| SCHEMBL27514353 | 0.84 | ESR1 (0.31) | ALDH1A1 | |
| SCHEMBL2143236 | 0.79 | — | — | |
| SCHEMBL25281081 | 0.79 | SLC6A3 (0.42) | OPRM1MAOAMAOB | |
| SCHEMBL6122804 | 0.77 | — | — | |
| SCHEMBL4447709 | 0.77 | ESR2 (0.48) | — | |
| SCHEMBL5430518 | 0.77 | SLC6A4 (0.41) | ALDH1A1 | |
| SCHEMBL43008 | 0.77 | KMT2A (0.34) | OPRM1MAOAMAOB | |
| SCHEMBL10953395 | 0.77 | — | — | |
| SCHEMBL29099764 | 0.77 | SLC6A4 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114981988-A | Metal oxide nanoparticle electron transport layers in perovskite semiconductor devices | 立方光伏股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| US-11685666-B2 | Metal oxide nanoparticles with alkylsiloxane ligands bonded thereto | CUBICPV INC. (US) | 2023-06-27 | — | — | US | disclosed |
| CN-114981988-A | Metal oxide nanoparticle electron transport layers in perovskite semiconductor devices | 立方光伏股份有限公司 | 2022-08-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685666-B2 | Metal oxide nanoparticles with alkylsiloxane ligands bonded thereto | MACO1, IPO4, ITGB5 | CYP19A1 4451/4885OPRD1 1892/4885OPRM1 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.